✦ LIBER ✦

S01.C PLM in patients with primary insomnia and in healthy controls

✍ Scribed by M. Hornyak

Book ID: 117775389
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 47 KB
Volume: 8
Category: Article
ISSN: 1389-9457
DOI: 10.1016/s1389-9457(07)70031-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sleep-related attentional bias in patien

✍ KAI SPIEGELHALDER; COLIN ESPIE; CHRISTOPH NISSEN; DIETER RIEMANN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

P.1.c.031 Effect of almorexant treatment

P.1.c.031 Effect of almorexant treatment on sleep variables in patients with primary insomnia compared with healthy controls

✍ G. Dorffner; P. Anderer; B. Saletu; G.M. Saletu-Zyhlarz; H. Danker-Hopfe; J. Bla 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Memory functioning in patients with prim

Memory functioning in patients with primary fibromyalgia and major depression and healthy controls

✍ Nils Inge Landrø; Tore C. Stiles; Helge Sletvold 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 675 KB

Gait in SWEDDs patients: Comparison with

Gait in SWEDDs patients: Comparison with Parkinson's disease patients and healthy controls

✍ Omar S. Mian; Susanne A. Schneider; Petra Schwingenschuh; Kailash P. Bhatia; Bri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 1 views

## Abstract Patients diagnosed with Parkinson's disease on clinical grounds who subsequently turn out to have normal dopamine transporter imaging have been referred to as SWEDDs (scans without evidence of dopaminergic deficits). Despite having clinical features similar to those of Parkinson's disea

Positron emission tomography in patients

Positron emission tomography in patients with fibromyalgia syndrome and healthy controls

✍ Yunus, Muhammad B. ;Young, Carter S. ;Saeed, S. Atezaz ;Mountz, James M. ;Aldag, 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

## Abstract ## Objective Abnormal brain findings have previously been described in fibromyalgia syndrome (FMS) by single‐photon–emission computed tomography. Our goal was to investigate change in regional cerebral glucose metabolism in people with FMS by positron emission tomography (PET) using ^1

Status of lipidsoluble antioxidants and

Status of lipidsoluble antioxidants and TRAP in patients with Crohn’s disease and healthy controls

✍ Genser, D; Kang, M-H; Vogelsang, H; Elmadfa, I 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB